Wingless (Wg) is an important signaling molecule in the development of Drosophila, but little is known about its signal transduction pathway. Genetic evidence indicates that another segment polarity gene, dishevelled (dsh) is required for Wg signaling. We have recently developed a cell culture system for Wg protein activity, and using this in vitro system as well as intact Drosophila embryos, we have analyzed biochemical changes in the Dsh protein as a consequence of Wg signaling. We find that Dsh is a phosphoprotein, normally present in the cytoplasm. Wg signaling generates a hyperphosphorylated form of Dsh, which is associated with a membrane fraction. Overexpressed Dsh becomes hyperphosphorylated in the absence of extracellular Wg and increases levels of the Armadillo protein, thereby mimicking the Wg signal. A deletional analysis of Dsh identifies several conserved domains essential for activity, among which is a so-called GLGF/DHR motif. We conclude that dsh, a highly conserved gene, is not merely a permissive factor in Wg signaling but encodes a novel signal transduction molecule, which may function between the Wg receptor and more downstream signaling molecules.
On the basis of these genetic interactions (for review, see Perrimon 1994 ), Dsh appears to be essential for Wg signaling. Dsh RNA is ubiquitous in embryonic epithelial cells and imaginal discs, and the gene is essential for Wg signal transduction in both of these tissues. The deduced amino acid sequence of Dsh predicts a protein of -7 0 kD Theisen et al. 1994) . The absence of a signal peptide or transmembrane domains suggests that Dsh is an intracellular protein, but its location has not been studied. Although the Dsh protein has little similarity with any known protein, one domain, -60 amino acids long, shows homology to a repeated sequence known as the GLGF repeat or discs-large homology region (DHR) (Bryant and Woods 1992; Cho et al. 1992 ). This motif is found in a number of other proteins, most of which are thought to be associated with cell junctions, including the protein encoded by the Drosophila tumor suppressor gene discs-large (Woods and Bryant 1991) . dsh is highly conserved in evolution: A number of dsh homologs in vertebrates have been isolated. A sequence comparison between dsh and the mouse dsh gene Dvl-1
shows an overall 50% identity at the amino acid level with almost complete conservation of the GLGF/DHR domain (Sussman et al. 1994 ).
The identification of dsh is a good example of the power of Drosophila to find genetic components in signaling pathways. Nevertheless, it does not become clear from these epistasis experiments whether dsh has a general permissive function or plays an active role as a signaling molecule. Moreover, there has been no biochemical analysis of the Dsh protein. In general, the possibilities for analyzing signaling events in cell culture have been limited in Drosophila, and the biochemical functions of Drosophila signaling genes have therefore often been inferred from their mammalian counterparts. Such cell culture assays are indispensable to study, for example, the kinetics of signaling events. But in the case of Wnt signaling, no suitable in vitro assays for mammalian Wnt proteins have been available. Recently, however, we have developed a cell culture assay for Wg activity, using a cell line (cl-8) from Drosophila imaginal discs (Van Leeuwen et al. 1994) . With this assay, we demonstrated that extracellular Wg protein is able to elevate levels of the Arm protein rapidly, involving changes in the phosphorylation status and stabilization of the Arm protein.
In this work we analyze the function of Dsh in Wg signaling. We show that Dsh becomes hyperphosphorylated in response to extracellular Wg. We also find that overexpression of Dsh in the absence of Wg leads to an increase in Arm levels, providing us with an assay for Dsh function. Through a deletion analysis of the Dsh cDNA and transfection into cl-8 cells, we show the importance of the GLGF/DHR domain for Dsh activity.
R e s u l t s

Antibodies specific for the Dsh protein
To characterize the Dsh protein, we raised antisera to fusion proteins containing different domains of Dsh. The positions of these domains are indicated in Figure 6 E. The amino-terminal domain (region I) was fused to the bacterial GST-protein and used to raise antisera in rats. A large internal domain of Dsh (region II) was fused to trpE and used to immunize rabbits. Figure 1A shows that in lysates of Drosophila embryos or the Drosophila imaginal disc cell line cl-8, the rat antiserum against Dsh region I reacts with several protein species of -7 0 kD, corresponding to the predicted size of the primary translation product of dsh (68850.50
Daltons . To show that these species were the product of the dsh gene, we performed an immunoprecipitation with the rabbit antiserum against region II and then analyzed the precipitated material by Western blot, using the anti-region I serum. We found the same species reacting (Fig. 1B) . Because region I and II do not overlap, this experiment demonstrates that the reaction of the antibodies with the two 70-kD proteins is specific.
Additional evidence for the specificity of these antisera was obtained by comparing whole cell lysates of Drosophila wild-type embryos with those of homozygous mutants carrying the d s h v26 allele. This allele has undergone a gene-internal deletion that has not been mapped exactly but takes out at least part of the proteinencoding domain of dsh . Figure 1 . Antibodies raised against Dsh specifically recognize the Dsh protein in cl-8 cells and wild-type embryos but not in Dsh mutant embryos. (A) Western blot of embryo or cl-8 cell lysates, using the anti-region I rat antiserum. {B) Immunoprecipitation from embryo or cl-8 cell lysates, using the anti-region II rabbit antiserum, followed by Western blotting using antiregion I rat antibodies. The cross-reacting bands around 55 kD are caused by the primary antibody reacting with the abundant immunoglobulin molecules. (C) Western blot comparing lysates of wild-type embryos with embryos homozygous mutant for the dsh v26 allele, using the rat anti-region I antibody. The smaller cross-reacting protein species are not specific for Dsh and most likely represent chorion proteins, abundantly present in these preparations.
When a collection of embryos m u t a n t for dsh (derived from germ-line clones carrying the dsh v26 allele) was analyzed, the 70-to 80-kD species were absent, whereas wild-type embryos did contain these proteins (Fig. 1C) . No novel smaller forms of Dsh were detected in dsh v26 embryos, but these could have been masked by other proteins.
In extracts of cultured cells and embryos, additional protein species were detected by the anti-region I antiserum. These could be either the products of Dsh-related genes or nonspecifically cross-reacting proteins and were ignored in the subsequent experiments.
In embryos and m cultured cells, Dsh is a cytoplasmic protein
We examined the cellular distribution of the Dsh protein by immunostaining methods, using the rat anti-region I serum. In whole-mount Drosophila embryos around cellular blastoderm, when the cells form a single-layered epithelium at the periphery of the embryo, the antibody revealed a cytoplasmic staining pattern ( Fig. 2A) . The apical side of the cells stained more intensely than basal regions (Fig. 2B) . Later, around gastrulation, Dsh staining was uniform, except for areas with a high cell density such as the proctodeum (Fig. 2C,D) . During the extended germ-band stage, the protein was also uniformly distributed, with no discernible regional or segmental differences (Fig. 2E, F) . In particular, there were no changes in Dsh distribution within the area of Wg expression (Fig.  2E ). During all of these stages, the Dsh protein appeared to be cytoplasmic, although at later stages a more punctate pattern was also seen (Fig. 2H) .
To control for the specificity of the antibody reaction, we stained a collection of embryos lacking the Dsh gene product. Apart from some large positively staining dots that were not seen in wild-type embryos and may represent dead cells, no cytoplasmic staining was apparent (Fig. 2I ). We examined a number of other Drosophila tissues, including wing imaginal discs, and found a similar distribution of the Dsh protein (not shown). In the cl-8 imaginal disc cell line, Dsh is also cytoplasmic (Fig. 2J) .
In cl-8 cells and in intact embryos, Dsh is phosphorylated in response to Wg
To analyze possible biochemical consequences of Wg signaling with respect to the Dsh protein, we used the in vitro system for Wg activity that we established recently {Van Leeuwen et al. 1994) . In these assays, cl-8 imaginal disc cells are cultured in m e d i u m conditioned by Schneider 2 cells overexpressing the heat shock-inducible Wg protein (S2-HS-wgl or cocultured with those cells, cl-8 cells respond to Wg by an increase in the intracellular concentration of the Arm protein (Van Leeuwen et al. 1994 ).
When we compared the Dsh protein in naive cl-8 cells with those that had been cultured in the presence of the Wg protein, we found additional, slower migrating forms of Dsh in the Wg-stimulated cells. {Fig. 3A). In response Campos-Ortega and Hartenstein (1985) . (Fig. 4) . Treatment with recombinant protein tyrosine phosphatase (PTP) did not affect the various modified forms. In addition, immunoprecipitation of cell or embryo lysates with the Dsh antibody, followed by Western blotting with antiphosphotyrosine antibodies, did not reveal a specific reaction {results not shown).This suggests that Dsh is modified by serine/threonine phosphorylation and that Wg treatment of cells results in additional phosphorylation on these residues. and allowed to recover for 3 hr before lysates were madc. In the embryos overexpressing Wg, modified forms of Dsh are detected.
A change in subcellular distribution of Dsh in fractionated cell extracts
We have looked for Wg-induced changes in the subcellular location of the Dsh protein by the immunostaining of cl-8 cells before and after incubation with Wg, or staining HS-wg embryos, yet no changes were detected (not shown). We then used cell fractionation methods as a more sensitive assay by which to examine Dsh distribution. Cells were fractionated by differential centrifugation into a soluble fraction containing cytoplasmic components and a membrane fraction containing plasma membrane and membranous organelles. The distribution of the Arm protein was a useful marker for the efficiency of the fractionation (Fig. 5A) . Peifer et al. (1994a, b) have shown that in response to the Wg signal in vivo, the cytoplasmic pool of the Arm protein increases, whereas the membrane-bound form of Arm is less affected. In naive cl-8 cells, Arm protein was present as two differently migrating forms, which is the result of differences in phosphorylation (Peifer et al. 1994a; Van Leeuwen et al. 1994) . Both forms were associated almost exclusively with the membrane fraction. In the cells that had been exposed to the Wg protein, a dramatic increase in the faster migrating (underphosphorylated) form of to Wg, Arm protein levels increased concomitantly with the modification of the Dsh protein {Fig. 3A). To control for the amount of protein loaded in each lane we used an antibody against e~-catenin, a protein with levels that are unaffected by Wg (Oda et al. 1993 ; data not shown). We could show that the modification of Dsh (and the Arm accumulation) was dependent on active Wg protein, because preincubation of the Wg-conditioned medium with a Wg-specific antibody, but not a preimmune antiserum, could block these effects {Fig. 3B,C).
To test whether Wg expression in vivo would also lead to modification of Dsh, we used a Drosophila strain carrying a heat shock-inducible wg transgene (HS-wg), shown previously to display a variety of wg-dependent effects that are mediated by Dsh (Noordermeer et al. 1992 ). In lysates of HS-wg embryos, an increase in Dsh modification was observed 3 hr after heat shock (Fig.  3D ). Arm was seen in the soluble cytoplasmic fraction and, to a much lesser extent, in the membrane fraction. The slower migrating (phosphorylated) form of Arm, detectable only in the membrane fraction, was not affected by Wg.
In naive cl-8 cells, we found most of the Dsh protein in the cytoplasmic fraction, in agreement with the staining results, although small amounts were also present in the membrane fraction (Fig. 5B) . The cells incubated with the Wg protein showed an overall increase in the amount of phosphorylation of Dsh. In addition, a significant fraction of the phosphorylated forms was present in the membrane fraction of Wg-exposed cl-8 cells. In particular, the hyperphosphorylated (slowest migrating) Dsh species was present in the membrane fraction only.
Overexpressed Dsh is modified and elevates Arm levels
Overexpression of an intracellular component of a signal transduction pathway is often able to bypass the need for an extracellular stimulus. To examine whether this could be achieved with Dsh, we transfected cl-8 cells with expression constructs driven by the inducible metallothionein promoter. Treatment of these cells with CuSO4 led to a considerable increase (at least 20-fold) in the amount of Dsh protein, compared with endogenous levels (Fig. 6A) . Concomitantly with the increase in Dsh protein levels, an increase in Arm levels was seen (Fig.  6C) . Moreover, overexpressed Dsh migrated as several different species, similar to those seen in untransfected cl-8 cells exposed to extracellular Wg protein. Analysis with phosphatases showed that these forms of Dsh had undergone phosphorylation similar to that caused by extracellular Wg {not shown), which, in conjunction with the elevation of Arm, indicates that overexpression of Dsh mimics Wg signaling.
A deletional analysis of Dsh
Having a functional assay for the Dsh protein in cl-8 cells, we made a series of Myc-tagged deletion mutants to map functional regions in the protein. As landmarks for these deletions, we used domains that are conserved between the Drosophila dsh and a mouse dsh homolog ( Fig. 6E ; Sussman et al. 1994; Theisen et al. 1994) . These included one deletion removing the GLGF/DHR domain and another one removing a conserved highly basic domain. Figure 6B shows that the various deleted forms were all detectable with the antiMyc antibody, and that they were all inducible with CuSO4, albeit to different levels. Two deletions removing carboxy-terminal regions of the Dsh protein had no effect on the elevation of Arm (Fig. 6B,D) . One of these removes a nonconserved part of the protein, whereas the other takes out a significant portion of a conserved domain (Fig. 6E) . However, deleting additional conserved sequences produced inactive forms of Dsh, as indicated by their failure to induce Arm protein accumulation. The internal deletion of the GLGF/DHR domain showed that this portion is essential for function, but the basic domain proved to be dispensable (Fig. 6B,D) .
Importantly, there is an absolute correlation between activity in the Arm assay and hyperphosphorylation of Dsh and vice versa. For example, the deletion mutant lacking the basic region (D-br) became modified (by phosphorylation as it is sensitive to phosphatase; data not shown) and was active on Arm. Conversely, the GLGF/DHR deleted form (D-dhr) was made at high levels after induction with CuSO4, but the protein migrated as a single species. This suggests that the hyperphosphorylated forms of Dsh, generated by either overexpression or by Wg stimulation, are the active forms.
Wg does not modify Dsh or Arm in $2 cells, but overexpression of Dsh in $2 ceils increases Arm levels
To corroborate the evidence that Dsh modification is a specific response to the Wg signal, we examined another Drosophila cell line, $2. We had observed previously that $2 cells do not respond to extracellular Wg, that is, Arm levels are not affected. Accordingly, in $2 cells overexpressing Wg after transfection of a heat shock promoterdriven Wg construct, levels of the Arm protein are unchanged (Fig. 7B) .
When we examined Dsh in $2 cells, we found that the protein migrated as a single species. Even in $2 cells overproducing the Wg protein, no modification of Dsh could be detected (Fig. 7A) . However, when we generated $2 cells overexpressing Dsh by transfection, we found that overexpressed Dsh was modified and gave rise to a (Fig. 7 C,D) . Hence, $2 cells are refractory to extracellular Wg, both with respect to Dsh modification and Arm stabilization, but overexpression of Dsh, an intracellular component of the Wg signaling pathway, overcomes this defect and bypasses the need for Wg.
Discussion
In Drosophila, a genetic approach has been taken to identify W g / W n t signaling components Perrimon 1994 ), but most of the genes found this way encode proteins w i t h o u t a k n o w n signaling function. Hence, little biochemical insight into Wg signaling has been provided, necessitating an in vitro approach. In this work we have sought to find biochemical evidence for the role of Dsh, using a cell culture assay for Wg protein activity as well as intact Drosophila embryos. We find that extracellular Wg leads to increased phosphorylation of Dsh. For a number of reasons, we consider it likely that the hyperphosphorylated Dsh is an active form of the protein. First, overexpression of Dsh itself, in the absence of extracellular Wg, leads to hyperphosphorylated forms of Dsh and to an increase in Arm level. Those deletion m u t a n t s of Dsh that are not active in the Arm assay are not modified. Second, we notice that Dsh is not modified in $2 cells, which is consistent with the lack of response of $2 cells to the Wg signal. In addition, the hyperphosphorylated Dsh species shows a different intracellular distribution. Whereas the protein is nor- mally mainly cytoplasmic, the hyperphosphorylated form appears to be associated with membranes.
These findings are reminiscent of molecular changes in other signaling pathways. A number of signaling molecules are activated when translocated to the plasma membrane. By constructing forms of these proteins that are constitutively attached to the plasma membrane, they become active in the absence of extracellular stimulation {Aronheim et al. 1994; Stokoe et al. 1994 ). In addition, overexpression of components in the tyrosine kinase pathway can lead to activation of downstream substrates, without activation of the upstream receptor (for review, see McCormick 1993) . For example, overexpression of Grb2, a protein with no apparent enzymatic activity, potentiates growth factor signaling by recruiting Son of sevenless to the membrane, allowing this complex to interact with activated receptor tyrosine kinases and Ras (Gale et al. 1993) . These effects are presumably caused by increasing concentrations of the effector, driving it in a complex with other proteins that normally only associate after activation of the receptor. On the basis of these observations and parallels with other pathways, a likely scenario for the action of the Dsh protein is that it is present in a soluble form in the cytoplasm, in various nonphosphorylated and phosphorylated forms. Signaling by Wg leads to additional phosphorylation and translocation of Dsh to an unidentified membrane component, and the protein becomes active in signal transduction. In this model we have to take into account that most of the Dsh protein is still cytoplasmic and that a minor fraction is associated with membranes. But although this membrane fraction is quantitatively a minor one, it is qualitatively different from the cytoplasmic forms, as it is hyperphosphorylated. It is very possible that the hyperphosphorylated Dsh has a dramatically different activity, possibly catalytic, compared with the cytoplasmic forms.
The modification of Dsh suggests the existence of an upstream serine/threonine kinase, which is coupled to or part of the Wg receptor. The identity of the protein kinase is not clear; preliminary in vitro kinase experiments suggest that it is not Zw3/Shaggy {K. Willert, F. van Leeuwen and R. Nusse, unpubl.) , which would be consistent with the genetic evidence that this enzyme is downstream of Dsh (Siegfried et al. 1994) . Overexpression of Dsh in $2 cells, which are not responsive to extracellular Wg, still leads to hyperphosphorylation of Dsh and to a significant increase in Arm levels. $2 cells may lack a component of Wg signaling that is upstream of Dsh, possibly the receptor for Wg.
In intact Drosophila embryos carrying a HS-wg transgene {Noordermeer et al. 1992), we find a similar modification of the Dsh protein when wg expression is ubiquitously induced at high levels. The longer lag time in vivo probably reflects the time required for synthesis and folding of active Wg protein and is similar to the minimal time required to induce ectopic expression of engrailed {Noordermeer et al. 1992). In wild-type embryos, we normally do not detect the hyperphosphorylated Dsh species, which may be attributable to the low levels of Wg present in these embryos relative to the HS-wg embryos.
A structure-function analysis of the Dsh protein reveals the importance of domains that are conserved between mouse and Drosophila. Most importantly, a relatively small deletion affecting the GLGF/DHR domain results in a protein that is no longer phosphorylated and is inactive in the Arm assay. It is not clear what the function of the GLGF/DHR domain is. It has been suggested that this region, which is present in a number of junctional proteins, would target proteins to the membrane or to junctional complexes. However, we find that Dsh is mainly a cytoplasmic protein, but it is possible that the GLGF/DHR repeat is involved in the regulated translocation of Dsh to the membrane by Wg activity.
The in vitro consequences of Wg on cultured cells reemphasize the important role of the Arm protein in Wg signaling. Both extracellular Wg and overexpression of intracellular Dsh lead to a significant increase in the concentration of the Arm protein. The cell fractionation studies shown in this paper and by Peifer et al (1994) show that the accumulation of Arm is mainly attributable to an increase in the cytoplasmic, soluble pool of Arm, rather than the membrane-associated fraction. Moreover, it is the hypophosphorylated form of Arm that increases in steady-state levels, in agreement with the postulated inhibitory role of the kinase Zw3 and the release of this inhibition through Wg signaling. These findings indicate that cytoplasmic Arm, being subject to
highly dynamic forms of regulation, may have functions that are not related to adherens junctions or to cell adhesion. Cytoplasmic Arm could be part of a complex including other Wg effectors The recent finding that its mammalian homolog [3-catenin is associated with the human tumor suppressor gene product adenomatous polyposis coli (APC) (Rubinfeld et al. 1993; Suet al. 1993) underscores the potential importance of these molecules as growth regulators. We have now shown that Dsh, a highly conserved protein, is biochemically upstream of Arm in Drosophila cells, corroborating the genetic evidence on the relationship between these genes and suggesting that a similar pathway exists in vertebrate cells. This modification of Dsh is the second known molecular effect brought about by a Wnt protein in vitro, next to the elevation of the Arm protein. Because Dsh acts early in Wg signaling, molecular changes in this molecule may provide important parameters in the search for the Wg receptor.
Materials and methods
Expression constructs
A 10-amino-acid sequence, derived from the human c-Myc protein, (EQKLISEEDLI (Evan et al. 1985) was added to the carboxyl termini of full-length and mutant forms of the Dsh protein. To achieve this, a derivative of pBluescript IIKS +, referred to as pBSII-myc, was constructed. Specifically, a 76-bp doublestranded oligonucleotide (5'-GGATCCCGCACTAAACCATG-GA C GAATTC GAG CAAAAGCTGATTTCTGAGGAGGAT-CTATGAAGCTTAAGTCGAC-3'), consisting of a BamHI site, 10 bases of the Dsh 5' leader sequence immediately upstream of initiation codon of the Dsh cDNA, an NcoI site (containing the initiator ATG codon), an EcoRI site (not present in the Dshcoding sequence), a 30-bp sequence encoding the Myc epitope, a stop codon (TGA), and 12-bp containing HindIII, AflII, and Sali sites, was cloned as a BamHI-SalI fragment into pBluescript IIKS +.
Polymerase chain reaction (PCR) was used for the construction of all Dsh-Myc fusions. Fidelity of the PCR reactions and subsequent cloning steps were confirmed by DNA sequencing. To generate the full-length Dsh-Myc protein and the Myctagged carboxy-terminal deletion mutants D-1 through D-5 (Fig.  6) , a 28-base sense primer (5'-TTCCATGGACGCGGA-CAGGGGCGGCGGG-3'), corresponding to an NcoI site (containing the ATG codon) and amino acids 2-7 of the Dsh protein, was used in combination with five different antisense primers, each containing an EcoRI site and 21 bases of the Dsh-coding region. To reconstruct full-length Dsh, a primer containing codons 617-623 of the Dsh cDNA was used. Similarly, primers containing codons 474--480 were used for the construction of D-I, codons 366-372 for D-2, codons 279-285 for D-3, codons 226-232 for D-4, and codons 109-115 for D-5. To generate two amino-terminal deletion mutants (D-6 and D-7), which both start at internal methionine 166 (Fig. 6) , another 28-base sense primer (5'-TTCCATGGGCAATCCGCTGCTGCAGCCG-3') was used in combination with antisense primers to reconstruct full-length Dsh and mutant (D-I). All PCR products were double digested with NcoI and EcoRI and inserted into the NcoIEcoRI cassette of pBSII-Myc, such that the Dsh-coding sequence was in-frame with the Myc epitope. Becauase of the presence of the EcoRI site, an additional two amino acids (EF) were generated between the Dsh protein sequence and the Myc epitope.
Another mutant (D-dhr, Fig. 6 ), which lacks about two-thirds of the DHR, was constructed as follows. A PCR product, used to generate mutant D-3, was digested with EcoRI, made bluntended with mung bean nuclease, and digested again with NcoI. The resulting 0.84-kb DNA fragment was ligated to a 3.8-kb NcoI-MscI fragment derived from the full-length Dsh-myc fusion construct. This resulted in a mutant lacking amino acids 286--336. A mutant that lacks a basic domain (D-br, Fig. 6 ), corresponding to amino acids 215-228 (RLQVRKKPQRRKKR), was constructed as follows: Taking advantage of a NarI site present at codon 229 (just downstream of this basic domain), another antisense primer (5'-ATAGGCGCCTGAACGCTGC-TATAGTCGGT-3') was used to create a new NarI site at codon 215. The PCR product encoding amino acids 1-214 was double digested with NcoI and NarI. A 0.65-kb NcoI-NarI fragment thus generated was ligated with a 4.2-kb NcoI-NarI fragment of the full-length Dsh--myc fusion construct (generated by complete NcoI and partial NarI digestions) creating a mutant lacking only these 14 basic amino acids.
All of the Dsh-myc fusion constructs in Bluescript were double digested with XbaI and SalI. After Klenow treatment, resulting blunt-ended fragments were inserted into the EcoRV site of vector pMK33 (Koelle et al. 1991) .
Cell culture, Wg protein assays, and transfections
The Drosophila wing imaginal disc cell line cl-8 (Peel and Milnet 1992) was cultured in M3 medium of Shields and Sang (Sigma), supplemented with 100 U/ml of penicillin/100 ~g/ml of streptomycin, 2% heat-inactivated fetal calf serum (FCS) (Sigma), 0.125 IU/ml of insulin (Sigma), and 2.5% of a fly extract prepared as described by Currie et al. (1988) . Cells were maintained at 25~ under air. $2 cells were grown in $2 medium (GIBCO) supplemented with 100 U/ml of penicillin/100 tzg/ml of streptomycin and 12.5% heat inactivated FCS. $2 cells transfected with a construct containing the heat shock promoter driving Wg expression (S2-HS-wg cells) have been described elsewhere (Cumberledge and Krasnow 1993) . Transfections and Wg protein assays, including antibody depletion experiments, were performed as described in Van Leeuwen et al. (1994) . Transfected cell lines were induced to overexpress Dsh by addition of 0.5 mM CuSO 4.
Antibody procluction
A cDNA fragment encoding amino acids 7-115 of the Dsh protein (region I), was amplified by PCR and cloned into pGEX-2TK (Pharmacia), to create a glutathione S-transferase (GST)-Dsh fusion protein. Similarly, a 663-bp PstI-XhoI fragment , corresponding to amino acids 175-395 (region tI), was cloned into the PstI-SalI sites in pATH 11 (Koerner et al. 1991) to create the TrpE-Dsh fusion protein. Both fusion proteins were produced in Escherichia coli strain HB101. Production of the GST-Dsh fusion protein was induced with 0.1 mM isopropyl-f3-D-thiogalactopyranoside (IPTG) at 37~ as described by Smith and Johnson (1988) , and fusion protein was purified by SDS-PAGE from crude bacterial lysates. Production of the TrpE-Dsh fusion protein was induced by 20 ~g/ml of indolacrylic acid (Sigma) at 30~ and purified by SDS-PAGE. Polyclonal antisera against these fusion proteins were raised in rats and rabbits.
Fly stocks and generation of germ-line clones
Germ-line clones homozygous mutant for the clsh v26 allele, were generated using the yeast recombinase-based FLP-DTS system as described . Homozygous mutant embryos were identified morphologically by a lack of segmentation, apparent at stage 11-12 (Klingensmith et al. 1989 ). Wild-type embryos (yellow-white) of the same stage were used as controls. To analyze the Dsh modification in HS-wg embryos (Noordermeer et al. 1992) , lysates were prepared from 3-to 17-hr-old embryos, 3 hr after heat shock (35 min, 37~
Cell lysates and immunoblot analysis C1-8 cells were grown to 80% confluency, washed with PBS, and lysed in lysis buffer (50 mM Tris at pH 7.5, 150 mM NaCI, 1% NP-40, 5 mM EDTA), supplemented with 20 ~g of leupeptin, 100 fag of aprotinin, and 180 ~tg of PMSF/ml. An equal volume of sample buffer (50 mM Tris at pH 6.8, 4% SDS, 10% [3-mercaptoethanol, 10% glycerol, 6 M urea) was added, and samples were boiled for 3 min prior to loading onto 7.5% SDS-polyacrylamide gels.
Drosophila embryos, 0-14 hr old, were dechorionated {except those shown in Fig. 1C ) with 50% bleach, rinsed with water, and homogenized in lysis buffer containing protease inhibitors. An equal volume of sample buffer was added, and the samples were boiled for 3 min prior to SDS-PAGE. Western blot analysis was performed exactly as described (Van Leeuwen et al. 1994) . The antibodies used for Western blotting include monoclonal anti-Arm antibody NI2-7A1 (Peifer 1993 ) at a dilution of 1: 1000; rat-polyclonal anti-a-catenin antibody DCAT-1 (Oda et al. 1993 ) diluted 1:1000; monoclonal anti-human c-Myc antibody 9El0 IOncogene Sciencel, diluted l:1000; monoclonal anti-phosphotyrosine antibody 4G10 (Upstate Biotechnology), diluted 1:1000; and rat polyclonal anti-Dsh region I antibody (Fig. 1) , at a concentration of 1:1000. Peroxidase-conjugated secondary antibodies against mouse IgG (Bio-Rad), rabbit IgG (BioRad), and rat IgG (Jackson Immuno Research Laboratories) were used at dilutions of 1:20,000.
Immunoprecipitation and phosphatase treatment
A subconfluent T75 flask of cl-8 cells (-107 cells), or 500 embryos, were lysed for 10 min in 1 ml of lysis buffer containing 1% SDS and 1 mM sodium vanadate (NaVO:s). The lysate was boiled for 10 min and diluted 10-fold with lysis buffer containing protease inhibitors and Na3VO4 to reduce the SDS concentration to 0.1%. After centrifugation at 10 "~ rpm for 20 min, 30 ~tl of rabbit anti-Dsh region II antiserum was added to the supernatant and incubated at 4~ overnight. The immunocomplex was precipitated with 25 ~1 of protein A-Sepharose beads (Pharmacia), washed three times with lysis buffer containing Na3VO4, and taken up in SDS-sample buffer. Alternatively, Dsh immunoprecipitates were washed with PAP buffer {40 mM MOPS at pH 5.5, 1 mM MgCI2, 50 mM NaC1, 1 mM PMSF) or PTP buffer [20 mM Tris at pH 7.2, 150 mM NaC1, 0.1% (vol/vol) 2-mercapto-ethanol, 10 mg/ml of BSA, 1 mM PMSF]. Immunocomplexes were then treated with 0.3 units of PAP (Sigma) in 50 ill of PAP buffer for 3 hr at 37~ or with 0.016 units of PTP (34-kD fragment; Boehringer Mannheim) in 30 }xl of PTP buffer for 2 hr at 37~ Immunocomplexes were taken up in SDS--sample buffer, boiled, and separated on SDS-polyacrylamide gels. Dsh protein was detected by Western blotting.
Cell fractionation
Two subconfluent T75 flasks of cl-8 cells, incubated for 2 hr in the presence or absence of $2 cells overproducing Wg, were washed twice with PBS, scraped, and collected by low speed centrifugation. Cells were resuspended in hypotonic buffer (10 mM Tris, 0.2 mM MgC12 (pH 7.4), supplemented with protease inhibitors, and phosphatase inhibitors; 0.5 ~M microcystin (GIBCO), and 1 mM Na3V04]. After a 10 min incubation on ice, the cells were disrupted by 25 strokes in a Dounce homogenizer (tight-fitting pestle). The homogenate was adjusted to a final concentration of 0.25 M sucrose and 1 mM EDTA. An aliquot of the homogenate was kept for later analysis. The homogenate was centrifuged at 1500g for 10 min at 4~ The supernatant fraction was removed, the pellet resuspended in the same buffer, and pelleted again. The two supernatants were combined and centrifuged at 100,000g for 1 hr at 4~ in a SW55 Ti rotor (Beckman Instruments). The supernatant was removed and kept at 4~ The pellet was resuspended in the same buffer and pelleted again at 100,000g. The two supernatants, denoted S100, were pooled and protein in these fractions was precipitated by adding an equal volume of 20% TCA. Precipitates were collected by centrifugation, neutralized with a 1 M Tris-base solution, and resuspended in lysis buffer containing protease and phosphatase inhibitors. The membrane pellet was resuspended in an equal volume of lysis buffer and incubated on ice for 10 min. This homogenate was centrifuged for 10 min at 10,000 rpm. The supernatant, denoted Pl00 (soluble), was collected. The pellet was extracted once more and centrifuged again. This insoluble pellet (Pl00 insoluble), was resuspended in the same volume of lysis buffer. An equal volume of SDS-sample buffer was added to all fractions, and the samples were boiled for 10 minutes.
lmmunohistochemistry and con focal microscopy
Embryos were dechorionated in 50% bleach and fixed in 4% paraformaldehyde in PBS/heptane for 15 min, followed by devitellinization in methanol. Embryos were washed three times for 15 min each, first in PBS, 0.3% Triton X-100 and then in PBS alone. After blocking in 2% goat serum in PBS for 1 hr, embryos were incubated at 4~ overnight with rat anti-Dsh region I, diluted 1:250 in PBS, 2% goat serum. After washing in PBS, embryos were incubated in FITC-conjugated secondary antibody (Sigma), 1:64 in PBS plus 2% goat serum. Finally, embryos were washed in PBS and mounted in Vectashield mounting medium (VectorJ.
Cells grown on two-well chamber slides were fixed in 4% paraformaldehyde, PBS, for 15 min and permeabilized in PBS, 0.3% Triton X100, for 15 min. Subsequent washes and antibody incubations were done in the same way as described for embryos. Confocal images were collected with a Bio-Rad MRC 1000 confocal laser setup attached to a Zeiss Axioscope microscope.
Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from
